Open AccessMinimally invasive surgery improves outcome of left ventricular assist device surgery in cardiogenic shock
Author(s) -
Leonhard Wert,
Arijit Chatterjee,
Güneş Doğan,
Jasmin S. Hanke,
Dietmar Boethig,
K. Tümler,
L. Christian Napp,
Dominik Berliner,
C. Feldmann,
C. Kuehn,
Andreas Martens,
Malakh Shrestha,
Axel Haverich,
Jan D. Schmitto
Publication year - 2018
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2018.01.27
Subject(s) - medicine , cardiogenic shock , ventricular assist device , surgery , clinical endpoint , heart failure , thoracotomy , heart transplantation , shock (circulatory) , cardiology , transplantation , randomized controlled trial , myocardial infarction
Left ventricular assist device (LVAD) (HVAD, Medtronic, Minneapolis, MN, USA) implantation is already a widely accepted treatment option for end-stage heart failure (HF) but also still considered as a rescue therapy for patients suffering from cardiogenic shock. Standard LVAD implantation techniques are often associated with high mortality rates and can result in severe complications, like bleeding or right heart failure (RHF). The aim of our study was to assess the outcome of Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 1 patients (so called "crash and burn" patients) undergoing a LVAD implantation by standard or less invasive surgery.